Vaccines, Vol. 10, Pages 359: Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

Industry News

Vaccines, Vol. 10, Pages 359: Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
Vaccines doi: 10.3390/vaccines10030359

Shopping cart0
There are no products in the cart!
Continue shopping
0